432 related articles for article (PubMed ID: 22921881)
1. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
[TBL] [Abstract][Full Text] [Related]
2. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
3. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
Rasovska H; Rektorova I
J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
[TBL] [Abstract][Full Text] [Related]
4. Statin-associated adverse cognitive effects: survey results from 171 patients.
Evans MA; Golomb BA
Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
[TBL] [Abstract][Full Text] [Related]
5. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.
Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F
J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
7. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
[TBL] [Abstract][Full Text] [Related]
8. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
[TBL] [Abstract][Full Text] [Related]
9. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
[TBL] [Abstract][Full Text] [Related]
10. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological screening performance and the association with activities of daily living and instrumental activities of daily living in dementia: baseline and 18- to 24-month follow-up.
Monaci L; Morris RG
Int J Geriatr Psychiatry; 2012 Feb; 27(2):197-204. PubMed ID: 22223145
[TBL] [Abstract][Full Text] [Related]
12. Is functional decline necessary for a diagnosis of Alzheimer's disease?
Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
14. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
[TBL] [Abstract][Full Text] [Related]
16. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
Molinuevo JL; Berthier ML; Rami L
Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
Riccio D; Solinas A; Astara G; Mantovani G
Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
Sparks DL; Sabbagh MN; Connor DJ; Lopez J; Launer LJ; Browne P; Wasser D; Johnson-Traver S; Lochhead J; Ziolwolski C
Arch Neurol; 2005 May; 62(5):753-7. PubMed ID: 15883262
[TBL] [Abstract][Full Text] [Related]
19. A retrospective pilot study on the development of cognitive, behavioral and functional disorders in a sample of patients with early dementia of Alzheimer type.
Coin A; Najjar M; Catanzaro S; Orru G; Sampietro S; Sergi G; Manzato E; Perissinotto E; Rinaldi G; Sarti S; Imoscopi A; Ruggiero E; Girardi A
Arch Gerontol Geriatr; 2009; 49 Suppl 1():35-8. PubMed ID: 19836614
[TBL] [Abstract][Full Text] [Related]
20. Statins and cognitive function in the elderly: the Cardiovascular Health Study.
Bernick C; Katz R; Smith NL; Rapp S; Bhadelia R; Carlson M; Kuller L;
Neurology; 2005 Nov; 65(9):1388-94. PubMed ID: 16275825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
